Susquehanna International Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-51,800
| Closed | -$212K | – | 14547 |
|
|
2022
Q1 | $212K | Buy |
51,800
+41,100
| +384% | +$149K | ﹤0.01% | 11109 |
|
|
2021
Q4 | $38K | Buy |
+10,700
| New | +$37.4K | ﹤0.01% | 12680 |
|
|
2021
Q3 | – | Sell |
-25,900
| Closed | -$113K | – | 13953 |
|
|
2021
Q2 | $113K | Sell |
25,900
-44,900
| -63% | -$183K | ﹤0.01% | 12030 |
|
|
2021
Q1 | $291K | Buy |
70,800
+59,200
| +510% | +$257K | ﹤0.01% | 10672 |
|
|
2020
Q4 | $46K | Sell |
11,600
-25,000
| -68% | -$80.9K | ﹤0.01% | 10771 |
|
|
2020
Q3 | $99K | Buy |
36,600
+17,900
| +96% | +$49.5K | ﹤0.01% | 9925 |
|
|
2020
Q2 | $51K | Buy |
+18,700
| New | +$52.2K | ﹤0.01% | 9748 |
|
|
2020
Q1 | – | Sell |
-28,500
| Closed | -$134K | – | 11149 |
|
|
2019
Q4 | $134K | Buy |
28,500
+7,900
| +38% | +$32.3K | ﹤0.01% | 9006 |
|
|
2019
Q3 | $69K | Sell |
20,600
-151,000
| -88% | -$497K | ﹤0.01% | 9695 |
|
|
2019
Q2 | $565K | Sell |
171,600
-252,600
| -60% | -$731K | ﹤0.01% | 7036 |
|
|
2019
Q1 | $1.28M | Buy |
424,200
+290,600
| +218% | +$942K | ﹤0.01% | 4526 |
|
|
2018
Q4 | $363K | Buy |
133,600
+120,600
| +928% | +$397K | ﹤0.01% | 6657 |
|
|
2018
Q3 | $44K | Sell |
13,000
-60,600
| -82% | -$187K | ﹤0.01% | 8883 |
|
|
2018
Q2 | $190K | Buy |
73,600
+53,700
| +270% | +$134K | ﹤0.01% | 8658 |
|
|
2018
Q1 | $44K | Buy |
19,900
+3,800
| +24% | +$8.55K | ﹤0.01% | 8989 |
|
|
2017
Q4 | $32K | Buy |
+16,100
| New | +$35K | ﹤0.01% | 9014 |
|
|
2017
Q3 | – | Sell |
-32,100
| Closed | -$103K | – | 9908 |
|
|
2017
Q2 | $103K | Buy |
32,100
+5,400
| +20% | +$15.3K | ﹤0.01% | 8675 |
|
|
2017
Q1 | $76K | Buy |
+26,700
| New | +$64.2K | ﹤0.01% | 8491 |
|
|
2016
Q4 | – | Sell |
-28,700
| Closed | -$48K | – | 10367 |
|
|
2016
Q3 | $48K | Buy |
+28,700
| New | +$35.2K | ﹤0.01% | 8134 |
|
|
2016
Q2 | – | Sell |
-10,700
| Closed | -$9K | – | 9575 |
|
|
2016
Q1 | $9K | Buy |
+10,700
| New | +$10.4K | ﹤0.01% | 8886 |
|
|
2015
Q4 | – | Sell |
-20,700
| Closed | -$35K | – | 10184 |
|
|
2015
Q3 | $35K | Sell |
20,700
-21,200
| -51% | -$41.6K | ﹤0.01% | 9430 |
|
|
2015
Q2 | $87K | Buy |
41,900
+23,200
| +124% | +$56.3K | ﹤0.01% | 9722 |
|
|
2015
Q1 | $51K | Buy |
+18,700
| New | +$47.4K | ﹤0.01% | 9147 |
|
|
2014
Q2 | – | Sell |
-242,700
| Closed | -$849K | – | 10230 |
|
|
2014
Q1 | $849K | Buy |
242,700
+167,400
| +222% | +$743K | ﹤0.01% | 5795 |
|
|
2013
Q4 | $337K | Sell |
75,300
-109,400
| -59% | -$446K | ﹤0.01% | 7406 |
|
|
2013
Q3 | $750K | Buy |
184,700
+127,400
| +222% | +$556K | ﹤0.01% | 5781 |
|
|
2013
Q2 | $238K | Buy |
+57,300
| New | +$221K | ﹤0.01% | 7193 |
|
Other funds holding ATRS
Susquehanna International Group's ATRS Position: Q2 2022 in Review
Susquehanna International Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 212,194 shares — an estimated $870K sold.
Susquehanna International Group first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $1.97M in Q1 2017. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Susquehanna International Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Susquehanna International Group sold 212,194 Antares Pharma, Inc. shares in Q2 2022, an estimated $870K.
- Susquehanna International Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
- Susquehanna International Group's Antares Pharma, Inc. position peaked at $1.97M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.